Work

Abstract PS1-01-10: Chronic Immune-Related Adverse Events after neoadjuvant pembrolizumab in early-stage triple-negative breast cancer: A Real-World cohort analysis

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps1-01-10

Authors: P. Matte, I. Hacini, P. H. Cottu, C. Helal, M. Mirabel, F. Coussy, F. Lerebours, E. Laas, E. Romano, L. Djerroudi, S. Hescot, P. Charles, B. Buecher, J. Pierga, L. Cabel, D. Loirat

Institutions: Institut Curie, Institute Mutualiste Montsouris

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129387287

Cites:

Cited by:

Related to: